Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The 2014 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update.

Literature DB >> 25360147

The 2014 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update.

Sherilyn K D Houle¹, Raj Padwal¹, Luc Poirier¹, Ross T Tsuyuki¹.

Abstract

Entities: Disease

Year: 2014 PMID： 25360147 PMCID： PMC4212441 DOI： 10.1177/1715163514535341

Source DB: PubMed Journal: Can Pharm J (Ott) ISSN： 1715-1635

× No keyword cloud information.

19 in total

Review 1. US pharmacists' effect as team members on patient care: systematic review and meta-analyses.

Authors: Marie A Chisholm-Burns; Jeannie Kim Lee; Christina A Spivey; Marion Slack; Richard N Herrier; Elizabeth Hall-Lipsy; Joshua Graff Zivin; Ivo Abraham; John Palmer; Jennifer R Martin; Sandra S Kramer; Timothy Wunz
Journal: Med Care Date: 2010-10 Impact factor: 2.983

2. Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors: Per Olav Vandvik; A Michael Lincoff; Joel M Gore; David D Gutterman; Frank A Sonnenberg; Pablo Alonso-Coello; Elie A Akl; Maarten G Lansberg; Gordon H Guyatt; Frederick A Spencer
Journal: Chest Date: 2012-02 Impact factor: 9.410

3. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades.

Authors: Finlay A McAlister; Kathryn Wilkins; Michel Joffres; Frans H H Leenen; George Fodor; Marianne Gee; Mark S Tremblay; Robin Walker; Helen Johansen; Norm Campbell
Journal: CMAJ Date: 2011-05-16 Impact factor: 8.262

4. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Introduction.

Authors: Alice Y Y Cheng
Journal: Can J Diabetes Date: 2013-03-26 Impact factor: 4.190

5. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement.

Authors:
Journal: Ann Intern Med Date: 2009-03-17 Impact factor: 25.391

6. Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study.

Authors: R B D'Agostino; A J Belanger; W B Kannel; J M Cruickshank
Journal: BMJ Date: 1991-08-17

Review 7. Clinical importance of coronary perfusion pressure in the hypertensive patient with left ventricular hypertrophy.

Authors: J M Cruickshank
Journal: Cardiology Date: 1992 Impact factor: 1.869

Review 8. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review.

Authors: C M Bennett; M Guo; S C Dharmage
Journal: Diabet Med Date: 2007-03-15 Impact factor: 4.359

9. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

Authors: Peter M Rothwell; F Gerald R Fowkes; Jill F F Belch; Hisao Ogawa; Charles P Warlow; Tom W Meade
Journal: Lancet Date: 2010-12-06 Impact factor: 79.321

Review 10. Pharmacist interventions to improve cardiovascular disease risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials.

Authors: Valérie Santschi; Arnaud Chiolero; Gilles Paradis; April L Colosimo; Bernard Burnand
Journal: Diabetes Care Date: 2012-12 Impact factor: 19.112

3 in total